Azithromycin for treatment of skin disorders
View Patent ↗Azithromycin has increased efficacy in treating acne and other skin conditions when administered systemically at low doses, below those previously known to produce a clinical antibiotic effect.
1. A pharmaceutical dosage form for oral administration comprising azithromycin in an amount less than 125 mg.
2. The pharmaceutical dosage form of claim 1 wherein the amount of azithromycin is 100 mg or less.
3. The pharmaceutical dosage form of claim 1 wherein the amount of azithromycin is 80 mg or less.
4. The pharmaceutical dosage form of claim 1 wherein the amount of azithromycin is 40 mg or less.
5. The pharmaceutical formulation of claim 1 that is a solid oral dosage form.
6. The pharmaceutical formulation of claim 5 that is in the form of a tablet or a capsule.
7. A kit for treating a skin disorder responsive to treatment with azithromycin comprising a container, a multiplicity of solid unit dosing forms of azithromycin within the container, wherein each solid dosing form within the container contains an amount of azithromycin of 125 mg or less, and instructions to administer one or more of the solid unit dosing forms containing a total amount of azithromycin of 125 mg or less at least three times per week.
8. The kit of claim 7 wherein the solid unit dosing forms are capsules or tablets.
9. The kit of claim 8 wherein the container contains a unit dose packaging.
10. The kit of claim 9 wherein the container is a blister pack.
11. The kit of claim 7 wherein the amount of azithromycin in each solid dosing form is 100 mg/day or less and the instructions are to administer one or more of the solid unit dosing forms containing a total amount of azithromycin of 100 mg or less at least three times per week.
12. The kit of claim 7 wherein the amount of azithromycin in each solid dosing form is 80 mg/day or less and the instructions are to administer one or more of the solid unit dosing forms containing a total amount of azithromycin of 80 mg or less at least three times per week.
13. The kit of claim 7 wherein the amount of azithromycin in each solid dosing form is 40 mg/day or less and the instructions are to administer one or more of the solid unit dosing forms containing a total amount of azithromycin of 40 mg or less at least three times per week.
14. A method for treating a skin disorder that is responsive to treatment with azithromycin in an individual suffering signs and/or symptoms therefrom comprising systemically administering azithromycin three or more days per week in an amount that is 125 mg of azithromycin or less per treatment day.
15. The method of claim 14 wherein the administration is for a duration of at least 20 days.
16. The method of claim 14 wherein the azithromycin is administered at an amount of 80 mg or less per treatment day.
17. The method of claim 16 wherein the azithromycin is administered at an amount of 40 mg or less per treatment day.
18. The method of claim 14 wherein the administration is at least every other day.
19. The method of claim 18 wherein the administration is at least 5 times per week.
20. The method of claim 19 wherein the administration is daily.
21. The method of claim 14 wherein the azithromycin is administered as a co-therapy with another medication that is effective in treating the skin disorder.
22. The method of claim 21 wherein the other medication is a topical retinoid and the skin disorder is acne.
23. The method of claim 14 wherein the skin disorder is acne.